Introduction
============

Recently, transrectal color Doppler sonography has been reported to be a very useful tool for measuring local blood flow in the female bovine reproductive tract \[[@B16]\]. This technique allows estimation of the corpus luteum (CL) physiological status since blood flow on the CL parenchyma reflects its structural and functional development. Moreover, Acosta and Miyamoto \[[@B2]\] hypothesized that in the preovulatory follicle, in the developing and in mature CL in cattle, structural and functional changes of the vasoactive system occur. This highlights the importance of blood flow in the lifespan of ovarian structures \[[@B2]\]. Luteal blood flow (LBF) gradually increases after ovulation along with increases in CL volume and plasma P4 concentrations from days (D) 2 to D5 of the estrus cycle \[[@B1]\]. LBF doubles during the static phase (D8\~16) and decreases rapidly during luteal regression (D17\~21) \[[@B8]\]. Thus, LBF values may be reliable predictors of luteal status.

The CL is one of the few adult tissues that exhibit regular periods of growth (CL formation), hormonal excretion, and luteolysis (CL regression) \[[@B3]\]. CL growth is predominantly regulated by angiogenic and luteotropic factors such as growth factors (i.e., insulin-like growth factors-1 and -2), oxytocin (OXY), and LH \[[@B17],[@B22]\]. Regression is initiated by luteolytic PGF~2α~ secreted by the endometrium \[[@B13]\] and is promoted by a complex and not well-elucidated cascade of mediators that include OXY. Nevertheless, the role of OXY in luteolysis has been previously studied. It appears that OXY is not a main factor in the initiation of luteolysis in cattle \[[@B26]\] although it can play a supporting and modulating role in early stages of luteolysis, as postulated in sheep \[[@B24]\] and cattle \[[@B25]\]. On the other hand, OXY has a stimulatory effect on progesterone (P4) secretion which is highest on D5\~7 of the estrus cycle and declines from D8 to D12 \[[@B26]\]. However, OXY no longer has any stimulatory effect on P4 secretion on D15\~18 \[[@B26]\]. Therefore, it was suggested that luteal oxytocin affects the luteal function as a luteotropic or luteolytic autocrine/paracrine factor within the CL depending on the day of the luteal phase. Nevertheless, whether this effect involves changes in LBF has never been determined. The purpose of this study was to investigate the effect of OXY administration on CL function during early to mid-diestrus by measuring luteal size (LS) and blood flow as well as peripheral plasma levels of P4.

Materials and Methods
=====================

Animals, reproductive management, and OXY administration
--------------------------------------------------------

This experiment was conducted at the Clinic for Cattle of the University of Veterinary Medicine, Hanover (Germany) in seven non-lactating multiparous Holstein-Friesian cows. The study was approved and conducted in accordance with the German legislation on animal welfare (Lower Saxony Federal State Office for Consumer Protection and Food Safety, Hannover, Germany). The animals were housed in tied stall barns and had *ad libitum* access to hay and water. They were healthy and examined for any reproductive tract abnormalities before enrollment in the experiment. Afterwards, all cycling cows underwent an ovulation-synchronization (Ovsynch) protocol \[[@B19]\] in which they received a gonadotropin-releasing hormone (GnRH) (2.5 mL; 10 µg, intramuscularly (im); Receptal; Intervet, USA), prostaglandin F~2α~ (PGF~2α~, 2 mL; 0.526 mg, im; Estrumate; Intervet, USA) 7 days later, and then GnRH (10 µg, im) 48 h after PGF~2α~ administration. At the time of the second GnRH administration, the size of the ovulatory follicle was measured with B-Mode sonography (8 MHz; General Electric, USA). The time of ovulation (D1) was determined by the disappearance of the ovulatory follicle between two consequent examinations performed at 24, 28, and 36 h after the last GnRH injection.

On D7, the cows randomly received OXY (100 IU, 10 mL, Oxykel; Agroscience, Germany) or placebo (PL; 10 mL of 0.9% sodium chloride) diluted in 1,000 mL of 0.9% sodium chloride solution. Infusion via catheter in the jugular vein lasted 60 ± 3 min. Before infusion, the ovaries were evaluated by transrectal sonography to determine that the CL had no cystic cavity. On D10, a second Ovsynch protocol was initiated in all cows with the animals assigned into the different OXY and PL groups receiving the exact reversed treatment protocol, according to a Latin square model.

Luteal size and LBF
-------------------

Size and blood flow of the CL were examined with B-mode and Power Doppler sonography (10 MHz; GE Healthcare, USA), respectively, just prior to and 0.5, 1, 1.5, 2, 3, 5, 12, 24, 36, 48, 60, and 72 h after infusion commencement. LBF was determined by the relative blood flow area (= maximum blood flow area near the maximum cross sectional area of the CL/maximum cross sectional area of the CL). The number of pixels with color was determined as a semiquantitative assessment of LBF using computer assisted image analysis software (PixelFlux; Chameleon Software, Germany). Three images each showing the maximum blood flow area and maximum cross sectional area of the CL were captured. The average from these three images were used for further analyses. Criteria for image selection included ones showing structures of interest that lacked artifacts, had constant color intensity and had intact borders with blood flow.

Blood samples and hormonal assays
---------------------------------

Blood samples were collected *via* indwelling jugular catheters just before OXY infusion and every 15 min for two hours after commencing infusion. After this period, blood was collected every 30 min for another 6 h and just after the sonographic examinations. All blood samples were collected in evacuated tubes containing ethylenediaminetetraacetic acid as an anticoagulant (S-Monovette; Sarstedt, Germany). The samples were stored on ice until they were centrifuged (3,500 × g for 15 min at 4℃) within 30 min after collection, and the plasma was stored at -20℃ until hormone analyses. Progesterone and prostaglandin metabolites (13,14-dihydro-15-keto-prostaglandin F~2α~, PGFM) were measured by an enzyme immunoassay according to Prakash et al. \[[@B18]\] and Mishra et al. \[[@B14]\] (monoclonal anti-P4 antibody, P-1922; Sigma, USA; polyclonal anti-PGFM antibody, provided by Professor Dr. H.H.D. Meyer, Institute for Physiology, Technical University of Munich, Germany; enzymes: 4-pregnen-3, 20-dione-3-O-carboxymethyloxime-horseradish peroxidase and PGFM-horseraddish peroxidase). The intra- and interassay coefficients of variation for P4 were both less than 10%; for PGFM, these coefficients were less than 7% and less than 10%, respectively.

Statistical analyses
--------------------

Statistical analyses were conducted using the statistical analysis system (ver. 9.1; SAS, USA). A Shapiro-Wilk test was performed for all outcome variables to determine the underlying distribution of the data. All variables showed a normal distribution. A repeated measures ANOVA using a general linear model within subject effects across time was conducted using proc glm (SAS, USA). Student\'s *t*-test was used to evaluate differences within animals at a specific time point using proc univariate (SAS, USA). *p*-values \< 0.05 were considered statistically significant. Data are presented as the mean ± SE.

Results
=======

The luteal size did not differ between the two groups at any time point ([Fig. 1](#F1){ref-type="fig"}). However, the size of the CL increased significantly over time in both groups (*p* = 0.02 and *p* = 0.001 for the PL and OXY groups, respectively). Additionally, LBF did not differ between the two groups over time ([Fig. 2](#F2){ref-type="fig"}). Although the LBF increased from 0.3\~0.4 cm^2^ to 0.7 cm^2^ in both groups, this difference was not significant ([Fig. 2](#F2){ref-type="fig"}). Plasma PGFM was not significantly different within the groups over time or between the groups at any time point ([Fig. 3](#F3){ref-type="fig"}). However, it should be mentioned that the animals in the OXY group showed greater variability compared to the PL group as demonstrated by the substantially larger SE for the OXY group ([Fig. 3](#F3){ref-type="fig"}). OXY infusion had a weak effect on the levels of P4 ([Fig. 4](#F4){ref-type="fig"}). Specifically, the P4 values tended to increase over time in the OXY group (*p* = 0.07) whereas there was no significant change in the PL group (*p* = 0.14). Moreover, the P4 levels of the OXY group differed significantly from those of the PL group 360 min after the infusion (4.2 *vs.* 3.1 ng/mL, *p* = 0.01) and tended to be higher at 450 min, 48 h, and 72 h (*p* = 0.08 for all).

Discussion
==========

Increased blood flow during normal CL development underlines the importance of angiogenesis during this process \[[@B8]\] because nearly every parenchymal cell in the mature CL is in contact with one or more capillaries \[[@B20]\]. The limited number of animals and large variation of the data in the present study were probably the reasons why increases in blood flow we observed did not reach statistical significant. CL growth following ovulation is rapid and comparable to that of tumors \[[@B4]\]. Although LH and PGF~2α~ are two of the primary endocrine factors controlling bovine CL function \[[@B29]\], modulatory or supporting roles of OXY in luteal development and regression have also been reported \[[@B10],[@B11]\]. In the present study OXY administration had no effect on the development of CLs, which continued to increase in size.

D7 of the estrus cycle coincides with the onset of the first follicular wave and a relatively increased concentration of estrogen \[[@B21]\]. It was previously reported that estrogens enhance the formation of endometrial OXY receptors, but P4 reduces the concentration of endometrial OXY receptors during the luteal phase by blocking the estrogen action \[[@B7]\]. On the other hand, a fully functional CL is present at the ovary on D7 and thus P4 production is high \[[@B21]\]. It is also known that the expression of OXY mRNA level is high during the early luteal phase in bovine CLs \[[@B9],[@B28]\]. Additionally, OXY directly stimulates P4 secretion in luteal cells \[[@B15]\]. Based on these findings, continuous infusion of high doses of OXY during the early luteal phase would be expected to alter P4 concentrations. However, only a weak effect was observed in the present study similar to previous findings \[[@B27]\]. The supporting role of OXY to P4 concentration diminishes from D7 onwards of the estrus cycle \[[@B26]\]. This could explain why there was a tendency for P4 concentrations to increase in the present study, since the CLs of some cows were still sensitive to OXY while others were not. Shirasuna et al. \[[@B23]\] recently confirmed this dual role of luteal OXY as luteotropic (during the early luteal and mid-luteal phases) and luteolytic (during the late luteal phase after initiation of the luteolytic cascade), highlighting the modulatory effect of OXY on local secretion of vasoactive substances within the CL.

Infusion of OXY in sheep has been previously reported to evoke a modest increase in PGF~2α~ secretion during the early and late but not the mid-luteal phases \[[@B5]\]. It seems likely that cyclical variation in the ability of OXY to evoke uterine PGF~2α~ secretion is due to cyclical changes in the concentration of endometrial OXY receptors \[[@B12]\]. Gilbert et al. \[[@B6]\] have also reported that there is no increase in PGFM (a stable metabolite of PGF~2α~) concentration after OXY administration. Results of the present study, showing that OXY administration had no effect on endometrial production of PGF~2α~ (measured as PGFM), support these findings. It is worth mention that large variations in PGFM concentrations were detected within both groups in our study. This could reflect variation of PGF~2α~ secretion as early as D7 in each animal since high or low concentrations were detected in the same animals regardless the group they were assigned to in the Latin square design (data not shown). However such fluctuations are difficult to explain and worth further investigation.

It was previously reported that luteolytic doses of PGF~2α~ affect blood flow in the mature CL \[[@B2]\]. The same effect was noticed in spontaneus luteolysis \[[@B16]\]. In contrast, no change in blood flow was observed in developing CLs (D4) after PGF~2α~ administration since plasma P4 levels and CL volume continues to increase after PGF~2α~ administration \[[@B16]\]. In the present study, OXY administration did not cause any increase in PGFM concentration. Although the CL is sensitive to luteolytic doses of PGF~2α~ during mid-cycle (D7), it seems unaffected by OXY administration, even at relative high doses (100 IU). The possible explanations for this observation are either that there were not enough OXY receptors in the uterus, or there was not enough available PGF~2α~ that could be released from the uterus. Nevertheless, the fact that there were no changes in CL blood flow, which continued to increase during and after infusion, supports the hypothesis, that OXY is not directly involved in the mechanism(s) governing blood flow in the developing CL. Further investigation is needed to elucidate the role of OXY in CL blood flow during different periods of the luteal phase.
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